Researchers from the University of Adelaide in Australia have found a new method to diagnose prostate cancer and it’s level of aggressiveness. The new method of detection involves analyzing semen fluids for microRNAs. Researchers found that microRNAs are incredibly accurate in detecting prostate cancer and its severity. The current method of detecting prostate cancer involves a PSA (prostate specific antigen) test, but it isn’t very specific and may code for non-cancerous conditions. The PSA test can result in numerous unneeded treatments. Testing for microRNAs in semen will allow physicians to provide better treatments for their patients because they will better understand whether or not an individual has prostate cancer and how severe their cancer is.
Contributing Author: Rosevine Azap